Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas.
Priscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, Eudocia Quant Lee, Nancy Wang, April F Eichler, Ugonma Chukwueke, Deborah A Forst, Isabel C Arrillaga-Romany, Jorg Dietrich, Zachary Corbin, Jennifer Moliterno, Joachim Baehring, Michael White, Kevin W Lou, Juliana Larson, Magali A de Sauvage, Kathryn Evancic, Joana Mora, Naema Nayyar, Jay Loeffler, Kevin Oh, Helen A Shih, William T Curry, Daniel P Cahill, Fred G Barker, Elizabeth R Gerstner, Sandro Santagata
Nature communications 2022;13(1):1325